Invus Public Equities, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1340097. 8 Form 4 filings on record with FilingPulse; latest filed 2024-12-12.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-13 to 2024-12-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 6 filings — 4,280,932 shares, $82,886,388 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 1,600,000 shares @ $41.65 ($66,640,000) in Scholar Rock Holding Corp, filed 2024-12-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | 10% owner | 2 | — | 6 legs · 2,009,433 sh · $82,397,639 | — |
| GLYCOMIMETICS INC (GLYC) | 10% owner | 4 | — | 9 legs · 2,271,499 sh · $488,749 | — |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | Director, 10% owner | 2 | — | — | 4 |
Form 4 filings — Invus Public Equities, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-12 | 4 | Scholar Rock Holding Corp (SRRK) jointly with Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, DEBBANE RAYMOND | Sale (S): 1,600,000 @ $41.65 | EDGAR |
| 2024-11-27 | 4 | Scholar Rock Holding Corp (SRRK) jointly with Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, DEBBANE RAYMOND | Sale (S): 208,272 @ $37.63 · Sale (S): 43,887 @ $38.43 · Sale (S): 126,442 @ $39.51 · Sale (S): 30,683 @ $40.14 · Sale (S): 149 @ $40.98 | EDGAR |
| 2024-08-09 | 4 | GLYCOMIMETICS INC (GLYC) jointly with Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, DEBBANE RAYMOND | Sale (S): 61,488 @ $0.18 · Sale (S): 260,873 @ $0.19 | EDGAR |
| 2024-08-07 | 4 | GLYCOMIMETICS INC (GLYC) jointly with Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, DEBBANE RAYMOND | Sale (S): 164,523 @ $0.19 · Sale (S): 55,732 @ $0.18 | EDGAR |
| 2024-08-05 | 4 | GLYCOMIMETICS INC (GLYC) jointly with Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, DEBBANE RAYMOND | Sale (S): 63,564 @ $0.22 · Sale (S): 286,200 @ $0.20 | EDGAR |
| 2024-07-30 | 4 | GLYCOMIMETICS INC (GLYC) jointly with Invus Public Equities Advisors, LLC, Siren, L.L.C., Invus Global Management, LLC, DEBBANE RAYMOND | Sale (S): 258,335 @ $0.24 · Sale (S): 363,949 @ $0.24 · Sale (S): 756,835 @ $0.22 | EDGAR |
| 2024-05-14 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal International S.C.A., Wittouck Amaury, Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Invus, L.P., Invus Public Equities Advisors, LLC, Invus Advisors, L.L.C. | Option exercise (M): 57,546,100 · Grant/award (A): 1,150,922 (derivative) @ $108.50 · Option exercise (M): 1,150,922 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal International S.C.A., Wittouck Amaury, Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Invus, L.P., Invus Public Equities Advisors, LLC, Invus Advisors, L.L.C. | Grant/award (A): 1,150,922 @ $108.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1340097 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →